Tag: Heart Bypass
Long-Term Outcomes of PCI, CABG Compared for Multivessel CAD
Findings for median follow-up of 11.8 years reported from multicenter, randomized, controlled trial terminated early due to slow enrollment
Ticagrelor DAPT Linked to Lower Risk for Vein Graft Failure in CABG
But addition of ticagrelor linked to increased risk for BARC type 2, 3, or 5 bleeding events versus aspirin
Coronary Artery Bypass Grafting Feasible in Patients Over 80
Procedure extends long-term survival but carries surgical risks
No Long-Term Advantage Seen for Off-Pump Versus On-Pump CABG
Time to all-cause death or repeated revascularization shorter with off-pump versus on-pump coronary artery bypass grafting
Troponin Levels and Mortality After Cardiac Surgery Examined
Cardiac troponin levels linked to increased risk for 30-day mortality substantially higher than thresholds cited for periprocedural myocardial injury
ECG-Based Algorithm Predicts Long-Term Survival After Cardiac Surgery
Findings seen among patients with left ventricular ejection fraction >35 percent undergoing valve and/or coronary bypass surgery
FFR-Guided PCI Not Noninferior to CABG in Three-Vessel CAD
Findings not consistent with prespecified noninferiority of fractional flow reserve-guided percutaneous coronary intervention
Women Less Likely to Undergo Guideline-Concordant CABG
Women have lower odds of receiving LIMA graft to the LAD artery, undergoing complete vascularization, receiving multi-arterial grafting












